نتائج البحث - "Isabelle C. Meijssen"

1

RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer

المؤلفون: Paul Roepman, Danielle Cohen, Stephen P. Finn, Cathal O'Brien, Hein F.B.M. Sleddens, Kim Monkhorst, Karin Weijers, Guido M.J.M. Roemen, Isabelle C. Meijssen, Ernst-Jan M. Speel, Tom van Wezel, Winand N.M. Dinjens, Mirjam C. Boelens, H.J. Dubbink, Willemina R. R. Geurts-Giele, Jan H. von der Thüsen, Kris G. Samsom, Erik Thunnissen, Teodora Radonic

المساهمون: RS: GROW - R2 - Basic and Translational Cancer Biology, Pathologie, Pathology

المصدر: Radonic, T, Geurts-Giele, W R R, Samsom, K G, Roemen, G M J M, von der Thüsen, J H, Thunnissen, E, Meijssen, I C, Sleddens, H F B M, Dinjens, W N M, Boelens, M C, Weijers, K, Speel, E J M, Finn, S P, O'Brien, C, van Wezel, T, Cohen, D, Monkhorst, K, Roepman, P & Dubbink, H J 2021, ' RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer ', Journal of Thoracic Oncology, vol. 16, no. 5, pp. 798-806 . https://doi.org/10.1016/j.jtho.2021.01.1619Test
Journal of Thoracic Oncology, 16(5), 798-806. Elsevier Science
Journal of Thoracic Oncology, 16(5), 798-806. International Association for the Study of Lung Cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b1e428c89911a1ba266b62b3867f640Test
https://doi.org/10.1016/j.jtho.2021.01.1619Test

2

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder

المؤلفون: Andrew S. Mason, Thomas van Doeveren, Angelique C. van der Made, Job van Riet, Geert J.L.H. van Leenders, Antoine G. van der Heijden, Harmen J.G. van de Werken, Kees Hendricksen, Joost L. Boormans, Charlotte S. Voskuilen, Tahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Bas W.G. van Rhijn, Jose A Nakauma-Gonzalez, Isabelle C. Meijssen, Hendrikus J. Dubbink, Winand N.M. Dinjens

المساهمون: Urology, Medical Oncology, Pathology

المصدر: International Journal of Cancer, 148(4), 981-987. Wiley-Liss Inc.
International Journal of Cancer, 148, 4, pp. 981-987
International Journal of Cancer
International Journal of Cancer, 148, 981-987

مصطلحات موضوعية: Male, bladder carcinoma, Cancer Research, medicine.medical_specialty, upper urinary tract carcinoma, Urology, clonality, Nephroureterectomy, Polymorphism, Single Nucleotide, 03 medical and health sciences, Molecular Cancer Biology, 0302 clinical medicine, fluids and secretions, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Medicine, Humans, In patient, Urinary Tract, urothelial carcinoma, Urothelial carcinoma, Upper urinary tract, Aged, Carcinoma, Transitional Cell, business.industry, Ureteral Neoplasms, Gene Expression Profiling, High-Throughput Nucleotide Sequencing, Genomics, Middle Aged, Tumor tissue, Kidney Neoplasms, Clone Cells, Clonal relationship, Oncology, Urinary Bladder Neoplasms, 030220 oncology & carcinogenesis, embryonic structures, Female, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffdc7f32e567558f0f79a336b747f53eTest
https://doi.org/10.1002/ijc.33327Test

3

Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer

المؤلفون: Thüsen J.H. von der, Melinda A. Pruis, A-M.C. Dingemans, Willemina R. R. Geurts-Giele, Isabelle C. Meijssen, W. Dinjens, Marthe S. Paats, Hendrikus J. Dubbink, Martijn P. Lolkema, Joachim G.J.V. Aerts

المساهمون: Medical Oncology, Pulmonary Medicine, Pathology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9)

المصدر: Lung Cancer, 140, 46-54. Elsevier Ireland Ltd

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, medicine.medical_treatment, sarcomatoid carcinoma, amplification, medicine.disease_cause, Targeted therapy, Exon, 0302 clinical medicine, Non-small cell lung cancer, Carcinoma, Non-Small-Cell Lung, diagnostics, CRIZOTINIB, met exon 14 skipping, Aged, 80 and over, Mutation, High-Throughput Nucleotide Sequencing, DNA, Neoplasm, Exons, Middle Aged, Proto-Oncogene Proteins c-met, Amplicon, Prognosis, MET Exon 14 Skipping Mutation, Survival Rate, 030220 oncology & carcinogenesis, Female, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Resistance against cMET inhibition, INHIBITION, Adenocarcinoma of Lung, PATIENT, DNA sequencing, target, resistance, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Next generation sequencing, met inhibitor, Biomarkers, Tumor, medicine, Humans, Lung cancer, Protein Kinase Inhibitors, Aged, Retrospective Studies, Crizotinib, Diagnostic Tests, Routine, business.industry, driver mutation, medicine.disease, 030104 developmental biology, business, Follow-Up Studies